Afzelin increased melanin content in human melanocytes.
Afzelin upregulated mRNA levels of MITF, tyrosinase, and TRP-1, but not TRP-2.
Afzelin led to an activation of p38 MAPK.
Afzelin regulated melanogenesis by increasing MITF gene expression through activation of the p38 MAPK.